Ticarcillin and clavulanic acid in combination were tested against 40 Pseudomonas aeruginosa isolates resistant to ticarcillin by disk diffusion. A total of 21 isolates (53%) were susceptible to ticarcillin-clavulanate by disk diffusion, under currently recommended criteria for ticarcilin susceptibility. Macro-broth dilution tests (ticarcillin plus clavulanic acid, 2 ,ug/ml) confirmed susceptibility (MIC <64 4g/ml) of only 8 (38%) of 21 isolates. Time-kill studies of disk diffusion susceptible isolates indicated 2 log10 or greater killing of most isolates at 6 h in broth containing ticarcillin (64 ,ig/ml) combined with clavulanic acid (1, 2, 5, or 10 ,ug/ml). After 6 h, regrowth was common in all concentrations of clavulanic acid except 10 ,ug/ml. Regrowth populations were resistant to ticarcillin-clavulanate by MIC determination. Poor bactericidal activity of ticarcillin-clavulanate against ticarcillin-resistant P. aeruginosa was confirmed, as most isolates did not undergo 99.9% or greater killing at 24 h in all concentrations of clavulanic acid. Serotype 0-11 was our most common serotype and was associated with disk diffusion "pseudosusceptibility." Concomitant disk diffusion testing of ticarcillinclavulanate and ticarcillin is recommended for testing the susceptibility of P. aeruginosa to ticarcillinclavulanate by disk diffusion. P. aeruginosa isolates resistant to ticarcillin should as a rule be considered also resistant to ticarcillin-clavulanate, despite apparent susceptibility by disk diffusion.
broadened the spectrum of activity of ticarcillin to include many otherwise resistant strains of Staphylococcus aureus, the family Enterobacteriaceae, and Bacteroides spp. (2, 6-8, 11, 15, 19) . Against ticarcillin-susceptible Pseudomonas aeruginosa, ticarcillin-clavulanate in combination has activity in vitro like that of ticarcillin alone (2, 6, 8, 11, 15) . Against ticarcillin-resistant P. aeruginosa, the activity of this combination has been less thoroughly studied, often with conflicting results. Some investigators have reported that most ticarcillin-resistant P. aeruginosa strains are resistant to ticarcillin-clavulanate by broth dilution MICs (19) , while others have found that the antipseudomonal activity of the combination is superior to that of ticarcillin alone by disk diffusion (T. Fosse, E.. Dupont, A. Rousset-Rouviere, D.
Darmuzey, M. David, and F. Duluc, Abstr. 14th Int. Congr.
Chemother. S-12-3, p. 119, 1985) or agar dilution MIC (14; R. Morisset, E.-Toma, M. Poisson, D. Phaneuf, and C. Vega, Proc. Conjoint Meet. Infect. Dis., Vancouver; no. 54, 1984) . Systematic correlations of disk diffusion, broth dilution, and time-kill susceptibilities of ticarcillin-resistant P. aeruginosa to ticarcillin-clavulanate have not been reported previously.
By disk diffusion testing, 21 (53%) of 40 ticarcillinresistant P. aeruginosa isolates from our medical center were susceptible to ticarcillin-clavulanate, under currently recommended criteria for ticarcillin-susceptible isolates (12) .
Because of the apparently high proportion of ticarcillinclavulanate susceptibility, we undertook to corroborate disk diffusion results by in vitro broth susceptibility tests. Additionally, we sought to determine whether ticarcillinclavulanate susceptibility among ticarcillin-resistant isolates was serotype dependent. Disk diffusion susceptibility tests. Disk diffusion susceptibility was evaluated by the method of the National Committee for Clinical Laboratory Standards with rapid inoculum preparation modification (3) . Isolates were grown on sheep erythrocyte agar for 18 to 24 h at 35°C. Five morphologically similar colonies were picked from the plates and suspended in 0.9% NaCl solution (saline) to equal a 0.5 McFarland barium sulfate turbidity standard. This bacterial suspension was repeatedly confirmed to contain approximately 109 CFU/ml as follows. A 0.5-ml sample of a 1:1,000 dilution in saline of this bacterial suspension was serially diluted 10-fold. A 0.01-ml sample from each dilution was cultured on sheep erythrocyte agar plates. After 18 to 24 h of incubation at 35C, the number of colonies on plates was multiplied by the appropriate dilution to verify that bacterial suspensions did indeed contain 1 x 109 ± 0.5 x 101 CFU/ml.
Within 5 min of preparation, the inoculum was evenly spread over Mueller-Hinton agar plates by a sterile swab and Time-kill studies. To assess bactericidal activity of ticarcillin-clavulanate against ticarcillin-resistant P. aeruginosa, time-kill studies were performed on all 21 isolates susceptible to ticarcillin-clavulanate by disk diffusion. Inocula were prepared by the methods described above. At zero time, ticarcillin (64 jxg/ml) in broth was added to glass tubes either alone or in combination with 1, 2, 5, or 10 ,ug of clavulanic acid per ml, which at these concentrations has no activity by itself against P. aeruginosa (18). Tubes containing bacterial suspension with or without 10 ,ug of clavulanic acid per ml served as controls. The final volume in each tube was 5 ml. Tubes were incubated at 35°C with continuous agitation by using a blood culture bottle shaker (New Brunswick Scientific Co., Inc., Edison, N.J.) to prevent regrowth of susceptible organisms caused by poor mixing with antimicrobial agents (13) . At 0, 6 , and 24 h, 0.5-ml samples from each tube were serially diluted 10-fold in 4.5 ml of sterile 0.9% NaCl solution (saline). The viable bacterial count was determined by culturing 0.01-ml samples from bacterial broth and saline tubes on blood agar and multiplying the resulting colony count by appropriate dilution. Also at 6 h, a duplicate ticarcillin-clavulanate (2 ,xg/ml) tube received an additional 2 ,ug of clavulanic acid per ml, and the viable cell count was determined similarly at 24 h. Regrowth was defined as 2 logl0 or greater reduction in viable cell count at 6 h, followed by growth resulting in 24-h viable cell counts similar to those of controls.
Serotyping. (2, 20) . More than half of these isolates appeared susceptible to ticarcillin-clavulanate by disk diffusion. Thus, we sought to further evaluate the degree of correlation of this test with macro-broth dilution MIC and time-kill studies. Knowledge of this correlation might be particularly important in centers such as ours where ticarcillin-resistant P. aeruginosa strains are common and ticarcillin-clavulante disk diffusion testing of P. aeruginosa is contemplated.
Our data strongly suggested that disk diffusion testing of ticarcillin-resistant P. aeruginosa overestimates susceptibility of these isolates to ticarcillin-clavulanate as measured by broth MIC and time-kill studies. Although more than half of our ticarcillin-resistant isolates initially appeared susceptible to ticarcillin-clavulanate by disk diffusion, we found a very high false-susceptibility rate of 62% by MIC. Poor bactericidal activity of the combination drug against ticarcillinresistant P. aeruginosa isolates was confirmed by time-kill studies in which only 14% of disk diffusion-susceptible isolates demonstrated 99.9% or greater killing at 24 h by ticarcillin (64 ,ug/ml) combined with clavulanic acid (2 ,xg/ml). Even in the presence of higher concentrations of clavulanic acid (5 and 10 ,ug/ml), effective killing occurred in only 29% of isolates. Despite frequent 2 log10 or greater killing at 6 h of ticarcillin combined with various concentrations of clavulanic acid, regrowth and rapid emergence of isolates with high-level resistance to ticarcillin-clavulanate after 24-h exposure to this drug combination were common. Although it is possible that higher clavulanic acid concentrations (>10 ,ug/ml) might have conferred better bactericidal activity in the presence of ticarcillin in time-kill studies, such concentrations probably have less clinical relevance since clavulanic acid levels of >5 ,ug/ml are obtained in blood only during the first 1 h of ticarcillin-clavulanate infusion (3 and 0.2 g, respectively), and not at all in blister fluid (4) .
Although the mechanism(s) responsible for the discrepancies between disk diffusion and broth susceptibility testing was not systematically evaluated, one explanation may be the lower number of organisms tested in agar tests (9, 23, 25) , with less opportunity for expression of resistant variants. Reports indicating superior activity of ticarcillinclavulanate against ticarcillin-resistant P. aeruginosa have been based on disk diffusion (Fosse et al., 14th ICC) or agar dilution susceptibility testing (14; Morisset et al., Proc. Conjoint Meet. Infect. Dis. 1984). Lack of significant activity of this drug combination against ticarcillin-resistant P. aeruginosa has often been demonstrated by broth dilution (2, 11, 19) .
The clinical relevance of poor correlation between disk diffusion and broth dilution susceptibility testing remains to be seen. Overestimation of susceptibility by disk diffusion testing of P. aeruginosa, with associated clinical failures, has been previously reported for cefoperazone (1) and moxalactam (16, 21) . The clinical importance of such discrepancy also has been emphasized for cefamandole against Enterobacter cloacae (17, 24) . Rylander et al. have demonstrated superior predictability of outcome for certain organisms in experimental infections by broth dilution MIC compared with agar dilution susceptibility testing (23) .
Serotype 0-11 predominated among our ticarcillinresistant P. aeruginosa isolates and was associated with ticarcillin-clavulanate susceptibility by disk diffusion. This serotype accounted for 24% of all P. aeruginosa isolates at our institution and has been an important cause of hospital outbreaks in other centers (10) .
In conclusion, disk diffusion susceptibility testing of ticarcillin-clavulanate against ticarcillin-resistant P. aeruginosa overestimates in vitro susceptibility to ticarcillin-clavulanate, with most isolates resistant by broth tests. We recommend concomitant disk diffusion testing with both ticarcillin and ticarcillin-clavulanate if disk diffusion susceptibility testing of ticarcillin-clavulanate against P. aeruginosa is per-on October 27, 2017 by guest http://aac.asm.org/ Downloaded from formed. Ticarcillin-clavulanate susceptibility by disk diffusion in the presence of ticarcillin resistance should be interpreted with caution and confirmed by broth susceptibility testing. Until the clinical efficacy of ticarcillin-clavulanate in ticarcillin-resistant P. aeruginosa infections is established, we concur (2, 12) that P. aeruginosa isolates resistant to ticarcillin should, as a rule, be considered resistant to ticarcillin-clavulanate.
